Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases

Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.

JAMA neurology·2026

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.

Frontiers in immunology·2026

C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics.

Cellular and molecular neurobiology·2026

Peripheral complement C4 protein in schizophrenia: Association with gene copy number and immune cell subtypes.

Proceedings of the National Academy of Sciences of the United States of America·2026

Why Is MS a More Frequent Complication of EBV Infection in Females?

Immunological reviews·2026

Cytotoxic T cell recognition of α-synuclein drives pathogenic immune responses in multiple system atrophy.

Proceedings of the National Academy of Sciences of the United States of America·2026

Spatially instructed checkpoints in antitumor NK cell immunity.

Trends in immunology·2026

Eating to heal: dietary interventions as emerging immune-based therapeutic strategies.

Trends in immunology·2026

Understanding HLA risk in immune-mediated inflammatory diseases requires antigen discovery.

Trends in immunology·2026

Tracking tumor and immune remodeling through myeloma therapy.

Trends in immunology·2026

Micrometastasis as a distinct immunobiological state and therapeutic target.

Trends in immunology·2026

Neutrophil-T cell dynamics predict tuberculosis outcome.

Trends in immunology·2026

Fat Necrosis: Correlation of Imaging Findings and Histopathology.

Journal of breast imaging·2026

Acute Fulminant Systemic Granulocytic Vasculitis Involving Arteries and Veins in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: An Autopsy Case Report.

Pathology international·2026

[Myelin oligodendrocyte glycoprotein antibody-associated disease].

Ugeskrift for laeger·2026

Inflammatory Rhabdomyoblastic Tumor: A Clinicopathological and Immunohistochemical Study of 22 Cases.

Applied immunohistochemistry & molecular morphology : AIMM·2026

Ocular Surface Disease as an Immune-related Adverse Event of Immune Checkpoint Inhibitor Therapy.

Cornea·2026

Clinical Practice Outcomes With Lecanemab for Alzheimer Disease.

Neurology open access·2026

Related Experiment Videos

Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases

Related Concept Videos

Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.

C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics.

Peripheral complement C4 protein in schizophrenia: Association with gene copy number and immune cell subtypes.

Why Is MS a More Frequent Complication of EBV Infection in Females?

Cytotoxic T cell recognition of α-synuclein drives pathogenic immune responses in multiple system atrophy.

Spatially instructed checkpoints in antitumor NK cell immunity.

Eating to heal: dietary interventions as emerging immune-based therapeutic strategies.

Understanding HLA risk in immune-mediated inflammatory diseases requires antigen discovery.

Tracking tumor and immune remodeling through myeloma therapy.

Micrometastasis as a distinct immunobiological state and therapeutic target.

Neutrophil-T cell dynamics predict tuberculosis outcome.

Fat Necrosis: Correlation of Imaging Findings and Histopathology.

Acute Fulminant Systemic Granulocytic Vasculitis Involving Arteries and Veins in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: An Autopsy Case Report.

[Myelin oligodendrocyte glycoprotein antibody-associated disease].

Inflammatory Rhabdomyoblastic Tumor: A Clinicopathological and Immunohistochemical Study of 22 Cases.

Ocular Surface Disease as an Immune-related Adverse Event of Immune Checkpoint Inhibitor Therapy.

Clinical Practice Outcomes With Lecanemab for Alzheimer Disease.

Related Experiment Videos

Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases

Related Concept Videos

Related Articles